N52.37
BillableErectile dysfunction following prostate ablative therapy
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is N52.37 an HCC code?
No. N52.37 is a billable ICD-10-CM code but does not map to any HCC category in V28, V24, ESRD, or RxHCC.
This code does not map to an HCC category in any model (V28, V24, ESRD, RxHCC).
What This Code Means
N52.37 is the ICD-10-CM diagnosis code for erectile dysfunction following prostate ablative therapy. Difficulty achieving or maintaining an erection that develops after prostate cancer treatment procedures such as radiation or surgical removal of prostate tissue. N52.37 sits in the ICD-10-CM chapter for diseases of the genitourinary system (n00-n99), within the section covering diseases of male genital organs (n40-n53).
N52.37 is a billable ICD-10-CM code but does not map to a payment HCC under the CMS-HCC V28, V24, ESRD, or RxHCC risk adjustment models. It can be reported on Medicare Advantage encounter data submissions but it does not contribute to a beneficiary's RAF score and therefore does not affect risk-adjusted payments to the plan.
This code requires documentation of the specific ablative therapy performed (radiation, cryotherapy, etc.) to support medical necessity.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for N52.37 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This code requires documentation of the specific ablative therapy performed (radiation, cryotherapy, etc.) to support medical necessity
- •Link this diagnosis to the prostate cancer treatment in the medical record to establish the causal relationship